Amryt Announces the Appointment of Sheila Frame as President Americas
06 avr. 2021 02h00 HE
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, April 6, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel...
Amryt Submits a New Drug Application to the US Food and Drug Administration for Oleogel-S10* (Filsuvez®)
31 mars 2021 02h00 HE
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, March 31, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel...
Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in FCS
30 mars 2021 02h00 HE
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, March 30, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel...
Amryt Announces Validation of its MAA by the EMA for Oleogel-S10* (Filsuvez®)
29 mars 2021 02h00 HE
|
Amryt Pharma plc
DUBLIN, Ireland, and Boston MA, March 29, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing...
Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy
23 mars 2021 03h00 HE
|
Amryt Pharma plc
Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept® (metreleptin) Indication in Partial Lipodystrophy DUBLIN, Ireland, and Boston MA, March 23, 2021, Amryt (Nasdaq: AMYT,...
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin)
22 mars 2021 03h00 HE
|
Amryt Pharma plc
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta® (metreleptin) DUBLIN, Ireland, and Boston MA, March 22, 2021, Amryt (Nasdaq: AMYT, AIM:...
Director/PDMR Shareholding
15 mars 2021 06h00 HE
|
Amryt Pharma plc
Amryt Pharma plc Director/PDMR Shareholding The following notification is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the...
Exercise of Options and Total Voting Rights
12 mars 2021 02h00 HE
|
Amryt Pharma plc
Exercise of Options and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 12, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to...
Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
11 mars 2021 06h30 HE
|
Amryt Pharma plc
Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 11, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Director/PDMR Shareholding
08 mars 2021 13h00 HE
|
Amryt Pharma plc
Grant of Options and Notification of Transactions by Persons Discharging Managerial Responsibilities DUBLIN, Ireland, and Boston MA, March 8, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global,...